Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

摘要

Background To estimate to what extent darunavir might be effective in patients failing distinct protease inhibitors (PIs), the genotypic resistance scores recently reported for the drug were examined in a large clinical HIV-1 drug resistance database.